Jordi contributes to the identification and the evaluation of investment opportunities from the scientific and business perspectives. He is particularly knowledgeable in molecular medicine.
Prior to joining Ysios in 2019, Jordi worked at Vida Ventures, in Boston, where he focused on opportunities in oncology, gene therapy and ophthalmology. Jordi has over 10 years’ experience in biomedical research: he did his PhD at the European Molecular Biology Laboratory (EMBL), where he studied fundamental aspects of non-coding RNA biology. As a postdoctoral fellow at Harvard University, he worked on developing novel therapeutic strategies for colorectal cancer by studying signaling pathways in cancer stem cells.
Jordi holds a bachelor´s degree in Biochemistry from the University of Barcelona and a PhD in molecular biology from EMBL.